Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Florida-based AxoGen touts an $18 million underwritten public offering of common stock, planning to expand commercial efforts for its peripheral nerve repair products.
Medtronic files the 1st module of a pre-market approval application with the FDA for its In.Pact Admiral drug-eluting balloon to treat peripheral artery disease.
From rampant hack-ability to risk transparency and hospital budgets, Medical Device Innovation, Safety & Security Consortium co-founder and executive director Dr. Dale Nordenberg tells MassDevice.com how a swath of healthcare industry stakeholders are coming together to build tools to address cybersecurity in medical devices.